Skip to main content
SpringerLink
Log in

Current knowledge ofChlamydia pneumoniae and atherosclerosis

  • Editorial
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC:Mycoplasma pneumoniae andChlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatric Infectious Disease Journal (1995) 14:471–477

    Google Scholar 

  2. Grayston JT, Aldous MB, Easton A, Wang SP, Kuo CC, Campbell LA, Altman J: Evidence thatChlamydia pneumoniae causes pneumonia and bronchitis. Journal of Infectious Diseases (1993) 168:1231–1235

    Google Scholar 

  3. Weiss SM, Hammerschlag MR: Are heart attacks infectious? A critical look at the link betweenChlamydia pneumoniae and atherosclerosis. Bulletin de l'Institut Pasteur (1997) 95:107–113

    Google Scholar 

  4. Danesh J, Collins R, Peto R: Chronic infections and coronary heart disease: is there a link? Lancet (1997) 350:430–436

    Google Scholar 

  5. Ramirez JA, and TheChlamydia pneumoniae/Atherosclerosis Study Group: Isolation ofChlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Annals of Internal Medicine (1996) 125:979–982

    Google Scholar 

  6. Jackson LA, Campell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT: Isolation ofChlamydia pneumoniae from a carotid endarterectomy specimen. Journal of Infectious Diseases (1997) 176:292–295

    Google Scholar 

  7. Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J: Rabbit model forChlamydia pneumoniae infection. Journal of Clinical Microbiology (1997) 35:48–52

    Google Scholar 

  8. Gupta S, Leatham E, Carrington D, Mendall MA, Kaski JC, Camm J: ElevatedChlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation (1997) 938:404–407

    Google Scholar 

  9. Garfinkel E, Bozovich G, Daroca A, Beck E, Mautner B: Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet (1997) 350:9075

    Google Scholar 

  10. Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M, Dumornay W, Mandel L, Smith P, Schachter P: Persistent infection withChlamydia pneumoniae following acute respiratory illness. Clinical Infectious Diseases (1992) 14:178–182

    Google Scholar 

  11. Hyman CL, Roblin PM, Gaydos CA, Quinn TC, Schachter J, Hammerschlag MR: Prevalence of asymptomatic nasopharyngeal carriage ofChlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reactionenzyme immunoassay and culture. Clinical Infectious Diseases (1995) 20:1174–1178

    Google Scholar 

  12. Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, Shani J, Frankel R, Penney K, Quinn TC, Hammerschlag MR, Schachter J: Failure to detectChlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. Journal of Infectious Diseases (1996) 173:957–962

    Google Scholar 

  13. Kark JD, Leinonen M, Paltiel O, Saikku P:Chlamydia pneumoniae and acute myocardial infarction in Jerusalem. International Journal of Epidemiology (1997) 26:730–738

    Google Scholar 

  14. Emre U, Roblin PM, Gelling M, Dumornay W, Rao M, Hammerschlag MR, Schachter J: The association ofChlamydia pneumoniae infection and reactive airway disease in children. Archives of Pediatrics & Adolescent Medicine (1994) 148:727–732

    Google Scholar 

  15. Kutlin A, Roblin PM, Hammerschlag MR: Antibody response toChlamydia pneumoniae infection in children with respiratory illness. Journal of Infectious Diseases (1998) 177:720–724

    Google Scholar 

  16. Wagels G, Rasmussen S, Timms P: Comparison ofChlamydia pneumoniae isolates by Western blot (Immunoblot) analysis and DNA sequencing of the omp 2 gene. Journal of Clinical Microbiology (1994) 32:2820–2823

    Google Scholar 

  17. Peterson EM, Cheng X, Qu Z, Maza LM: Characterization of the murine antibody response to peptides representing the variable domains of the majour outer membrane protein ofChlamydia pneumoniae. Infection and Immunity (1996) 64:3354–3359

    Google Scholar 

  18. Kern DG, Neill MA, Schachter J: A seroepidemiologic study ofChlamydia pneumoniae in Rhode Island — evidence of serologic cross-reactivity. Chest (1993) 104:208–213

    Google Scholar 

  19. Moss TR, Darougar S, Woodland RM, Nathan M, Dines RJ, Cathine V: Antibodies toChlamydia species in patients attending a genitourinary clinic and the impact of antibodies toChlamydia pneumoniae andChlamydia psittaci on the sensitivity and the specificity ofChlamydia trachomatis serology tests. Sexually Transmitted Diseases (1993) 20:61–65

    Google Scholar 

  20. Ozanne G, Lefebvre J: Specificity of the microimmunofluorescence assay for the serodiagnosis ofChlamydia pneumoniae infections. Canadian Journal of Microbiology (1997) 38:1185–1188

    Google Scholar 

  21. Maurin M, Etienne J, Raoult D: Serological cross-reactions betweenBartonella andChlamydia species: implications for diagnosis. Journal of Clinical Microbiology (1997) 35:2283–2287

    Google Scholar 

  22. Noordhoek GT, Kolk AHJ, Bjune G, Catty D, Dale JW, Fine PEM, Godfrey-Faussett P, Cho SN, Shinnick T, Svenson SB, Wilson S, Embden JDA: Sensitivity and specificity of PCR for detection ofMycobacterium tuberculosis: a blind comparison study among seven laboratories. Journal of Clinical Microbiology (1994) 32:277–284

    Google Scholar 

  23. Taylor-Robinson D:Chlamydia pneumoniae in arteries: a tale of the unexpected. Journal of Infection (1997) 35:97–98

    Google Scholar 

  24. Hammerschlag MR: Antimicrobial susceptibility and therapy of infections caused byChlamydia pneumoniae. Antimicrobial Agents and Chemotherapy (1994) 38:1873–1878

    Google Scholar 

  25. Roblin PM, Hammerschlag MR: Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates ofChlamydia pneumoniae from adults and children with community-acquired pneumonia. Antimicrobial Agents and Chemotherapy (1998) 42:194–196

    Google Scholar 

  26. Anderson R, Theron AJ, Feldman C: Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils. Inflammation (1996) 20:693–705

    Google Scholar 

  27. Xu G, Fujita J, Negayama K, Yuube K, Hojo S, Yamaji Y, Kawanishi K, Takahara J: Effect of macrolide antibiotics on macrophage functions. Microbiology and Immunology (1996) 40:473–479

    Google Scholar 

  28. Leach AJ, Shelby-James TM, Mayo M, Gratten M, Laming AC, Currie BJ, Mathews JD: A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance ofStreptococcus pneumoniae. Clinical Infectious Diseases (1997) 24:356–362

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pediatrics and Medicine, State University of New York Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 49, 11203-2098, Brooklyn, New York, USA

    M. R. Hammerschlag

Authors
  1. M. R. Hammerschlag
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hammerschlag, M.R. Current knowledge ofChlamydia pneumoniae and atherosclerosis. Eur. J. Clin. Microbiol. Infect. Dis. 17, 305–308 (1998). https://doi.org/10.1007/BF01709451

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01709451

Search

Navigation